Le Lézard
Classified in: Health, Covid-19 virus
Subjects: LEG, AVO

Statement: U.S. Conference of Mayors Supports Congressional Efforts to Pass Additional Emergency COVID-19 Relief for Cities


WASHINGTON, April 9, 2020 /PRNewswire/ -- Below is a statement by Tom Cochran, CEO and Executive Director of the United States Conference of Mayors, on the legislative proposals put forward today by Congressional leaders on additional emergency COVID-19 relief for cities:

"We applaud and fully support the legislative proposals put forward today by Congressional leaders to continue to provide financial relief to cities of all sizes. Mayors are on the front line of fighting the COVID-19 pandemic and the provisions in today's proposals will help give cities resources they desperately need. We especially appreciate the use of the CDBG structure for distributing funds directly to our cities at a time when they are needed quickly. We also applaud provisions to support small businesses as they suffer from the negative economic impacts of the virus.

"In this time of national crisis, we encourage Congress to come together in a bipartisan way to pass this much-needed legislation."

About the United States Conference of Mayors -- The U.S. Conference of Mayors is the official nonpartisan organization of cities with populations of 30,000 or more. There are nearly 1,400 such cities in the country today, and each city is represented in the Conference by its chief elected official, the mayor. Like us on Facebook at facebook.com/usmayors, or follow us on Twitter at twitter.com/usmayors.

SOURCE U.S. Conference of Mayors


These press releases may also interest you

at 23:19
Summit Clinical Research LLC ("Summit") is deeply saddened by the death of Co-Founder and Chairman Dr. Stephen Harrison. Summit mourns Dr. Harrison and extends its heartfelt condolences to his family and loved ones.   During an illustrious 30-year...

at 22:15
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...

at 21:59
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

at 21:27
Labcorp , a global leader of innovative and comprehensive laboratory services, announced today that it has been selected as the winning bidder for select assets of Invitae, a leading medical genetics company.  Before the transaction can proceed,...

at 21:19
Invitae , a leading medical genetics company, announced that Labcorp , a global leader of innovative and comprehensive laboratory services, has been selected...

at 21:05
Valcare Medical, Inc., a leading innovator in transcatheter-based mitral...



News published on and distributed by: